- An
antiplatelet drug (antiaggregant), also
known as a
platelet agglutination inhibitor or
platelet aggregation inhibitor, is a
member of a
class of pharmaceuticals...
- Clopidogrel, sold
under the
brand name
Plavix among others, is an
antiplatelet medication used to
reduce the risk of
heart disease and
stroke in those...
-
related to
antiplatelet drugs and
thrombolytic drugs by mani****ting the
various pathways of
blood coagulation. Specifically,
antiplatelet drugs inhibit...
- has not been
found to be
useful in
secondary stroke prevention. The
antiplatelet medications,
aspirin and clopidogrel, are both
recommended for secondary...
-
glycoprotein IIb/IIIa inhibitors, also GpIIb/IIIa inhibitors, is a
class of
antiplatelet agents.
Several GpIIb/IIIa
inhibitors exist:
abciximab (abcixifiban)...
-
continued indefinitely, as well as
another antiplatelet agent such as
clopidogrel or
ticagrelor ("dual
antiplatelet therapy" or DAPT) for up to
twelve months...
- a
medication used to
reduce the risk of
thrombotic strokes. It is an
antiplatelet drug in the
thienopyridine family which is an
adenosine diphosphate (ADP)...
-
duration of dual-
antiplatelet therapy after stent implantation: a pre-specified
analysis from the
PRODIGY (Prolonging Dual-
Antiplatelet Treatment After...
-
stroke were
treated with
antiplatelet therapy only.
Previous studies did not
identify a
clear benefit of PFO
closure over
antiplatelet therapy in reducing...
-
Different antithrombotics affect different blood clotting processes:
Antiplatelet drugs limit the
migration or
aggregation of platelets. Anticoagulants...
